Upstream Bio, Inc.
UPB
$17.63
-$0.11-0.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -172.29% | -150.32% | -79.51% | -415.54% | -424.03% |
| Total Depreciation and Amortization | 223.08% | 230.77% | 250.00% | -17.65% | -10.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 499.32% | 136.69% | 1,202.28% | 127.11% | 107.22% |
| Change in Net Operating Assets | -116.81% | -287.57% | 67.28% | -76.55% | 480.14% |
| Cash from Operations | -388.29% | -134.40% | -21.74% | -189.73% | 5.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 110.99% | -1,640.43% | 903.00% | -85.84% | -160.08% |
| Cash from Investing | 110.95% | -1,640.43% | 899.47% | -88.50% | -159.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -81.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 131.34% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -99.56% | -100.36% | 203,594.74% | -3,382.00% | 116.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -263.36% | -4,584.41% | 1,463.48% | -289.76% | 38.90% |